drug · small molecule
duvelisib
Marketedupdated 3mo agoby Secura Bio Inc🔗 ChEMBL
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 2Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 15 investigational indications.
targets
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoformPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
all catalysts(0)
nothing on the calendar yet
Trials studying duvelisib
- phase1A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
- phase3A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With Relapsed/Refractory Nodal T Cell Lymphoma With T Follicular Helper (TFH) Phenotype
- phase2Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS
- phase1Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
- phase2Duvelisib Maintenance After Autologous Stem Cell Transplant in T-Cell Lymphomas
- phase2Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
- phase1Duvelisib in Combination With BMS-986345 in Lymphoid Malignancy
- phase2Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jan 5, 2029
~2.4 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Apr 26, 2035method-of-use (U-2412)US 12213983
- Apr 26, 2035method-of-use (U-2412)US 12213983
- Sep 24, 2032compositionUS 8193182
- Sep 24, 2032compositionUS 8193182
- May 17, 2032compositionUS RE46621
- May 17, 2032compositionUS RE46621
- Jan 10, 2032formulationUS 11312718
- Jan 10, 2032formulationUS 11312718
- Jan 10, 2032method-of-use (U-2412)US 9840505
- Jan 10, 2032method-of-use (U-2413)US 9840505
- Jan 5, 2029method-of-use (U-2412)US 92169822.4y
- Jan 5, 2029method-of-use (U-2412)US 92169822.4y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 40m ago
Found something off?
comments(0)
5-min edit window · permanent after that